KLTO
Klotho Neurosciences, Inc.
NASDAQ: KLTO · HEALTHCARE · BIOTECHNOLOGY
$0.52
+0.00% today
Updated 2026-04-30
Market cap
$56.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
9.5M
Klotho Neurosciences, Inc. (KLTO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-198.30%
ROA
-71.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-913.00 | — | — | — |
| 2021 | $0.00 | $-1.11M | — | — | — |
| 2022 | $0.00 | $-598593.00 | — | — | — |
| 2023 | $0.00 | $-707458.00 | — | — | — |
| 2024 | $0.00 | $-6.15M | — | — | — |